Trial Profile
The effect of ivabradine versus standard pharmacotherapy on hemodynamics in patients with chronic heart failure (CHF) and the analysis of the possible mechanism of improvement
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2021
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; ACE inhibitors; Digoxin; Spironolactone
- Indications Chronic heart failure
- Focus Therapeutic Use
- 07 Aug 2021 Status changed from completed to discontinued.
- 25 Jan 2019 Status changed from discontinued to completed.
- 25 Jan 2019 Status changed from completed to discontinued.